ONC‐212 treatment of healthy B‐cells had no effect on CD49d expression or on cell migration but significantly increased the expression of CXCR4 (Figure S2), suggesting another way in which ONC‐212 may specifically target CLL cells. Here, ITGA4 is linked to B-cell chronic lymphocytic leukemia.